A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study-Reference-Cited by-同舟云学术

A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study

Published:2011-10-04 Issue:3 Volume:106 Page:643-649
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Warren Katherine E.,Gururangan Sri,Geyer J. Russell,McLendon Roger E.,Poussaint Tina Young,Wallace Dana,Balis Frank M.,Berg Stacey L.,Packer Roger J.,Goldman Stewart,Minturn Jane E.,Pollack Ian F.,Boyett James M.,Kun Larry E.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Neurology (clinical),Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-011-0709-z.pdf

Reference39 articles.

1. Friedman H, Dolan M, Pegg A et al (1995) Activity of temozolomide in the treatment of central nervous system xenografts. Cancer Res 55:2853–2857

2. Stupp R, Hegi M, Gilbert M, Chakravarti A (2007) Chemoradiotherapy in malignant glioma: Standard of care and future directions. J Clin Oncol 25:4127–4136

3. Yung A, Prados M, Yaya-Tur R et al (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 17:2762–2771

4. Brada M, Hoang-Xuan K, Rampling R et al (2006) Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12:259–266

5. Sankar A, Thomas D, Darling J (1999) Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomide. Anticancer Drugs 10:179–185

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lonidamine Increases the Cytotoxic Effect of 1-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-3-(2-chloroethyl)-3-nitrosourea via Energy Inhibition, Disrupting Redox Homeostasis, and Downregulating MGMT Expression in Human Lung Cancer Cell Line;ACS Omega;2024-08-17

2. DNA Adducts in Cancer Chemotherapy;Journal of Medicinal Chemistry;2024-03-29

3. QSAR and Chemical Read-Across Analysis of 370 Potential MGMT Inactivators to Identify the Structural Features Influencing Inactivation Potency;Pharmaceutics;2023-08-21

4. Hypoxia and CD44 receptors dual-targeted nano-micelles with AGT-inhibitory activity for the targeting delivery of carmustine;International Journal of Biological Macromolecules;2023-08

5. Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance;Cancers;2023-07-01